Oxandrolone

CAS No. 53-39-4

Oxandrolone( NSC 67068 | SC 11585 | Oxandren )

Catalog No. M14898 CAS No. 53-39-4

Oxandrolone(SC11585) is a synthetic hormone with anabolic and androgenic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Oxandrolone
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxandrolone(SC11585) is a synthetic hormone with anabolic and androgenic properties.
  • Description
    Oxandrolone(SC11585) is a synthetic hormone with anabolic and androgenic properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 67068 | SC 11585 | Oxandren
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    53-39-4
  • Formula Weight
    306.44
  • Molecular Formula
    C19H30O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    C[C@]12CC[C@H]3[C@@H](CC[C@@H]4[C@]3(C)COC(C4)=O)[C@@H]1CC[C@@]2(O)C
  • Chemical Name
    (4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao J, et al. Steroids, 2004. 69(5): p. 357-66.
molnova catalog
related products
  • Zanoterone

    Zanoterone is an AR antagonist (androgen receptor).Zanoterone has antitumor activity for the treatment of genitourinary disorders and oncological disorders and may be used in the study of prostate cancer.

  • 2-hydroxy Flutamide

    2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR)?for the treatment of prostate cancer.

  • AR antagonist 1

    AR antagonist 1 is a potent antagonist of the androgen receptor. It binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PROTAC ARD-266.